- Previous Close
1.0100 - Open
1.0360 - Bid --
- Ask --
- Day's Range
1.0200 - 1.1680 - 52 Week Range
1.0080 - 9.9900 - Volume
300,417 - Avg. Volume
127,122 - Market Cap (intraday)
52.516M - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
-- - EPS (TTM)
-1.6800 - Earnings Date Sep 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.27
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
www.carmatsa.comRecent News: ALCAR.PA
View More
Performance Overview: ALCAR.PA
Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALCAR.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALCAR.PA
View MoreValuation Measures
Market Cap
43.17M
Enterprise Value
90.25M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.63
Price/Book (mrq)
--
Enterprise Value/Revenue
16.17
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-54.82%
Return on Equity (ttm)
--
Revenue (ttm)
6.93M
Net Income Avi to Common (ttm)
-53.35M
Diluted EPS (ttm)
-1.6800
Balance Sheet and Cash Flow
Total Cash (mrq)
11.42M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-34.21M
Research Analysis: ALCAR.PA
View MoreCompany Insights: ALCAR.PA
ALCAR.PA does not have Company Insights